Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy

James B. Wetmore, Jiannong Liu, Thy P. Do, Kimberly A. Lowe, Areef Ishani, Brian D. Bradbury, Geoffrey A. Block, Allan J. Collins

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


BackgroundLittle is known about changes in parathyroid hormone (PTH), calcium and phosphorous levels after parathyroidectomy in hemodialysis patients. We studied the effects of parathyroidectomy on these biochemical values in a large cohort of patients receiving maintenance hemodialysis. MethodsThis retrospective cohort study included patients identified in both the United States Renal Data System and the database of a large dialysis organization who underwent parathyroidectomy in 2007-09, were aged ≥18 years, had Medicare Parts A and B as primary payer and had received hemodialysis for ≥1 year pre-parathyroidectomy. Descriptive statistics were calculated for continuous variables; categorical variables were used to characterize the population and evaluate monthly laboratory and medication use; median values were calculated for laboratory measures. ResultsAmong 1402 parathyroidectomy patients, mean age was 48.9 years, 52.4% were males, 58.8% were African American and mean dialysis duration was 7.5 years. Median PTH levels increased over the year before parathyroidectomy from 1039 to 1661 pg/mL and decreased afterward to 98 pg/mL at 1 month; levels remained ≥897 pg/mL for 10% of patients. Median calcium levels fell from 9.6 mg/dL before to 7.9 mg/dL 1 month after parathyroidectomy; levels were ≤7.1 mg/dL for 25% and remained ≤7.2 mg/dL for the lowest 25% at 3 months. Median phosphorous level was 6.8 mg/dL immediately before parathyroidectomy, decreased to 3.8 mg/dL immediately after and reached 5.8 mg/dL at 1 year. ConclusionsWhile PTH levels dropped after parathyroidectomy for most patients, surgery was sometimes ineffective in reducing levels and sometimes led to over-suppression. Hypocalcemia could be profound and long lasting, suggesting the need for prolonged vigilance.

Original languageEnglish (US)
Pages (from-to)103-111
Number of pages9
JournalNephrology Dialysis Transplantation
Issue number1
StatePublished - Jan 1 2016

Bibliographical note

Publisher Copyright:
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA.


  • dialysis
  • end-stage renal disease
  • mineral metabolism
  • parathyroidectomy
  • secondary hyperparathyroidism


Dive into the research topics of 'Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy'. Together they form a unique fingerprint.

Cite this